Clinical Trial Update: Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b

View source ↗

Summary

A completed clinical trial update on adherence to Betaferon (interferon beta-1b) in people with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Betaferon (interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis | Status: COMPLETED